BRCA1 and neoplasm: Even if our study is limited to a little subset of PDAC and germline, analysis of variants identified on tumoral tissues was possible only in eight cases, it is noteworthy that NGS approach on tumor tissue let us to identify the exon 16 deletion of BRCA1 in the germline setting of a PDAC patient.